The future of clinical laboratories: more testing or knowledge services?

[1]  C. Schmid,et al.  Why clinicians are natural bayesians , 2005, BMJ : British Medical Journal.

[2]  A. Jeremias,et al.  Narrative Review: Alternative Causes for Elevated Cardiac Troponin Levels when Acute Coronary Syndromes Are Excluded , 2005, Annals of Internal Medicine.

[3]  S. Eichinger,et al.  Deep vein thrombosis , 2005, The Lancet.

[4]  J. Mbanya,et al.  Standardisation of glycated haemoglobin , 2004, BMJ : British Medical Journal.

[5]  M. Plebani.  What information on quality specifications should be communicated to clinicians, and how? , 2004, Clinica chimica acta; international journal of clinical chemistry.

[6]  William A Ghali,et al.  d-Dimer for the Exclusion of Acute Venous Thrombosis and Pulmonary Embolism , 2004, Annals of Internal Medicine.

[7]  Diederick E Grobbee,et al.  Test research versus diagnostic research. , 2004, Clinical chemistry.

[8]  A. Wu,et al.  Evaluation of imprecision for cardiac troponin assays at low-range concentrations. , 2004, Clinical chemistry.

[9]  Curt D. Furberg,et al.  The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk , 2004, Clinical chemistry and laboratory medicine.

[10]  S. Shortell,et al.  Crossing the quality chasm: implications for health services administration education. , 2004, The Journal of health administration education.

[11]  Cas Weykamp,et al.  IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. , 2004, Clinical chemistry.

[12]  J. Ornato,et al.  Impact of the troponin standard on the prevalence of acute myocardial infarction. , 2003, American heart journal.

[13]  M. Burke,et al.  Clinical laboratory consultation: appropriateness to laboratory medicine. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[14]  Mario Plebani,et al.  Appropriateness in programs for continuous quality improvement in clinical laboratories. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[15]  G. Siest.  First Santorini Conference: From Genetic Variations to Risk Prediction and Pharmacogenomics , 2003 .

[16]  A. Keech,et al.  Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment , 2003, The Lancet.

[17]  David Moher,et al.  Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. , 2003, Clinical chemistry.

[18]  David Moher,et al.  Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. , 2003, Radiology.

[19]  Mario Plebani,et al.  Charting the course of medical laboratories in a changing environment. , 2002, Clinica chimica acta; international journal of clinical chemistry.

[20]  C P Price,et al.  Point of Care Testing , 1999, BMJ : British Medical Journal.

[21]  C. Price.  Evidence-based laboratory medicine: supporting decision-making. , 2000, Clinical chemistry.

[22]  M Plebani,et al.  The Changing Face of Clinical Laboratories , 1999, Clinical chemistry and laboratory medicine.

[23]  W. Gibler,et al.  National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. , 1999, Clinical chemistry.

[24]  W. H. Hannon,et al.  International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. III. Comparability of apolipoprotein A-I values by use of international reference material. , 1993 .

[25]  F. Dati,et al.  International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. , 1991, Clinical chemistry.